Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 31 - Medicinal preparations containing organic active ingredients
Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912)
03/2003
03/20/2003WO2003022839A1 Tetrahydropyran derivatives and their use as therapeutic agents
03/20/2003WO2003022837A1 Heterocycle-carboxamide derivatives as raf kinase inhibitors
03/20/2003WO2003022836A1 Nitrogen-containing heterocyclic compounds and their use as raf inhibitors
03/20/2003WO2003022835A1 17beta-hydroxysteroid dehydrogenase type 3 inhibitors for the treatment of androgen dependent diseases
03/20/2003WO2003022833A1 Pyridylfurans and pyrroles as raf kinase inhibitors
03/20/2003WO2003022832A1 Pyridylfurans and pyrroles as raf kinase inhibitors
03/20/2003WO2003022830A1 Benzothiepine ileal bile acid transport inhibitors
03/20/2003WO2003022825A1 Benzothiazepine derivatives for the treatment of hyperlipidemia
03/20/2003WO2003022824A1 Oxazolidinone and/or isoxazoline as antibacterial agents
03/20/2003WO2003022821A1 Heterocycle derivative having 20-hete-producing enzyme inhibitory activity
03/20/2003WO2003022815A1 3-(4,5,6,7-tetrahydroindol-2-ylmethylidiene)-2-indolinone derivatives as kinase inhibitors
03/20/2003WO2003022814A1 Indole derivatives
03/20/2003WO2003022813A1 Indole derivatives, process for producing the same and drugs containing the same as the active ingredient
03/20/2003WO2003022809A2 Urea-compounds active as vanilloid receptor antagonists for the treatment of pain
03/20/2003WO2003022806A2 Cbi analogues of cc-1065 and the duocarmycins
03/20/2003WO2003022804A2 Method for the preparation of crystalline tetrahydrobenzothiepines
03/20/2003WO2003022801A1 Reverse hydroxamic acid derivatives
03/20/2003WO2003022799A1 Ccr-3 receptor antagonists v
03/20/2003WO2003022787A1 Method for preparing unsaturated fatty hydroxy-acids and esters thereof, their use in pharmaceutical and/or cosmetic compositions
03/20/2003WO2003022324A1 Medical devices containing rapamycin analogs
03/20/2003WO2003022310A1 Prostaglandin compositions and methods of treatment for male erectile dysfunction
03/20/2003WO2003022309A1 Remedies for allergic diseases
03/20/2003WO2003022305A1 Method for treating coumarin-induced hemorrhage
03/20/2003WO2003022298A2 Use of a protein of the crmp family for treating diseases related to the immune system
03/20/2003WO2003022296A1 Method and composition for treating immune complex associated disorders
03/20/2003WO2003022291A1 Derivatives of partially desulphated glycosaminoglycans as heparanase inhibitors, endowed with antiangiogenic activity and devoid of anticoagulating effect
03/20/2003WO2003022290A1 Medicinal compositions for diabetic neuropathy
03/20/2003WO2003022289A1 Erythromycin derivative-containing medicine for treatment for or prevention of tuberculosis
03/20/2003WO2003022288A1 Nutritional compositions for controlling blood glucose level
03/20/2003WO2003022287A1 USE OF 3β-HYDROXY-5-SPIROSTENE AS DRUGS FOR PREVENTION OR TREATMENT OF CARDIOVASCULAR DISEASES OR CONDITIONS FOR INHIBITION OF TUMORS AND DECREASING OF BLOOD LIPIDS
03/20/2003WO2003022286A1 Benzothiazepine and benzothiadiazepine derivatives with ileal bile acid transport (ibat) inhibitory activity for the treatment hyperlipidaemia
03/20/2003WO2003022285A1 Heterocyclic substituted 2- (4-phenoxy) pyridine derivatives and related compounds as sodium channel blockers for the treatment of neuronal damage and neurodegenerative conditions
03/20/2003WO2003022284A1 Methods of treating pulmonary disease
03/20/2003WO2003022283A1 Combination of an adenosine a2a receptor antagonist and an antidepressant or anxiolytic
03/20/2003WO2003022282A1 Use of 4-pyridylmethylphthalazines for cancer treatment
03/20/2003WO2003022280A2 3-glyoxlylamideindoles for treating cancer
03/20/2003WO2003022279A1 Inhalation compositions comprising tricyclic 5,6-dihydro-9h-pyrazolo (3,4-c)-1,2,4-triazolo (4,3-alpha) pyridines and a tiotropium salt
03/20/2003WO2003022278A1 Contraceptives
03/20/2003WO2003022277A1 Arylsulfonamide derivatives for use as ccr3 antagonists in the treatment of inflammatory and immunological disorders
03/20/2003WO2003022276A1 Aryl substituted pyridinecarboxamides and their use as sodium channel blockers
03/20/2003WO2003022275A1 Inhalation compositions comprising tricyclic 5,6-dihydro-9h-pyrazolo (3,4-c)-1,2,4-triazolo (4,3-alpha) pyridines
03/20/2003WO2003022274A2 2-aroylimidazole compounds for treating cancer
03/20/2003WO2003022273A1 Methods of treating cytokine mediated diseases
03/20/2003WO2003022272A1 Appetite-stimulating agents and remedies for anorexia
03/20/2003WO2003022271A1 Lymphocytic activation inhibitor and remedial agent for autoimmune disease
03/20/2003WO2003022270A1 Transdermal administration of an enalapril ester
03/20/2003WO2003022269A1 Novel use of substituted aminomethyl chromans for the treatment of movement disorders and of adverse effects induced by drugs administered to treat extrapyramidal movement disorders
03/20/2003WO2003022268A1 A combination and method of treatment of cancer utilizing a cox-2 inhibitor and a 3-hydroxy-3-methylglutaryl-coenzyme-a (hmg-coa) reductase inhibitor
03/20/2003WO2003022267A1 Pharmaceutical compositions containing terbinafin and use thereof
03/20/2003WO2003022266A1 Hypoestoxides, derivatives and agonists thereof for use as inhibitors of angiongenesis
03/20/2003WO2003022265A1 Oily paclitaxel composition and formulation for chemoembolization and preparation method thereof
03/20/2003WO2003022264A1 Paclitaxel mixed composition and water-in-oil type emulsion formulation for chemoembolization and preparation method thereof
03/20/2003WO2003022263A1 Pharmaceutical composition comprising gamma-butyrobetaine for stimulating the sexual activity and potency
03/20/2003WO2003022262A1 Pharmaceutical composition comprising gamma-butyrobetaine
03/20/2003WO2003022261A1 Method of alleviating pain
03/20/2003WO2003022260A1 Use of methotrexate and l-arginine for the preparation of a medicament for treatment of uterine myoma
03/20/2003WO2003022259A1 Methods of preparing and using 2-hydroxy derivatives of sibutramine and its metabolites
03/20/2003WO2003022258A1 Aryloxypropylamines as chemosensitizing agent in the treatment of cancer
03/20/2003WO2003022253A1 Dosage forms having prolonged active ingredient release
03/20/2003WO2003022252A2 Combinatorial type (several vehicles within a housing) controlled release drug delivery device
03/20/2003WO2003022249A1 New self emulsifying drug delivery system
03/20/2003WO2003022248A1 Oily paclitaxel composition and formulation for chemoembolization and preparation method thereof
03/20/2003WO2003022247A1 Injectable composition of paclitaxel
03/20/2003WO2003022246A1 Treating effects of excessive reactive oxygen species
03/20/2003WO2003022244A1 Vascular occlusion solid-phase agent with immobilised platelet binding agent
03/20/2003WO2003022242A1 Preparation of sustained release pharmaceutical composition
03/20/2003WO2003022239A2 Stable water in oil aminophylline emulsions
03/20/2003WO2003022231A1 Compositions for stimulating and promoting hair growth
03/20/2003WO2003022224A2 Cox-2 function and wound healing
03/20/2003WO2003022218A2 Carboxylate-gated-nitroxide (cgn) compounds and compositions and methods of use thereof
03/20/2003WO2003022217A2 Treatment of excessive radiation (e.g. sunburn) exposure
03/20/2003WO2003022216A2 Biaryl substituted purine derivatives as potent antiproliferative agents
03/20/2003WO2003022211A2 Method of preventing mucositis
03/20/2003WO2003022209A2 Crystalline forms of valacyclovir hydrochloride
03/20/2003WO2003022207A2 Method and composition for reducing sebum secretion in mammals
03/20/2003WO2003022052A1 Method for expression of small rna molecules within a cell
03/20/2003WO2003011241A8 Utilization of creatinine and/or creatinine derivatives in cosmetic and dermatological preparations
03/20/2003WO2003007940A8 Lactam and thiolactam derivatives as anesthetic and conscious sedation agents
03/20/2003WO2003002175A3 Enhanced systemic absorption of intradermally delivered substances
03/20/2003WO2003002117A3 Niaciamide and derivatives in combination with aminosugar
03/20/2003WO2003002104A3 Use of corrinoids in the treatment of skin diseases
03/20/2003WO2003000195A3 Method and material for treating immune diseases
03/20/2003WO2002102808A3 (PYRIDO/THIENO)-[f]-OXAZEPIN-5-ONE DERIVATIVES AS POSITIVE MODULATORS OF THE AMPA RECEPTOR
03/20/2003WO2002102344A3 No-synthase inhibitor and use thereof
03/20/2003WO2002100845A8 Hv protease inhibitors, compositions containing the same, their pharmaceutical uses and materials for their synthesis
03/20/2003WO2002100836A8 Compounds, compositions and methods for modulating beta-amyloid production
03/20/2003WO2002100319A3 Method for cleaning hard gelatine capsules
03/20/2003WO2002099075A3 Prmts as modifiers of the p53 pathway and methods of use
03/20/2003WO2002098363A3 NON-PEPTIDE GnRH AGENTS, PHARMACEUTICAL COMPOSITIONS AND METHODS FOR THEIR USES, AND PROCESSES FOR PREPARING THEM
03/20/2003WO2002098226B1 Method for reducing muscle fatigue through administration of adenosine triphosphate
03/20/2003WO2002096366A3 Metallotetrapyrrolic photosensitizing agents for use in photodynamic therapy
03/20/2003WO2002096354A3 Enhancement of oral bioavailability of non-emulsified formulation of prodrug esters with lecithin
03/20/2003WO2002094768A3 Aza hydroxylated ethyl amine compounds
03/20/2003WO2002092102A3 Treatment of conditions relating to hormone deficiencies by administration of progestins
03/20/2003WO2002092077A3 Use of lipoic acid for suppressing undesired haematological effects of chemotherapy and/or radiotherapy
03/20/2003WO2002092042A3 Pharmaceutical and cosmetic compositions against skin aging
03/20/2003WO2002091993A3 Estrogen receptor modulators
03/20/2003WO2002087556A9 Probucol monoesters and their use to increase plasma hdl cholesterol levels and improve hdl functionality
03/20/2003WO2002087509A3 Colloidal metal compositions and methods
03/20/2003WO2002083113A3 Aerosol compositions containing formoterol and a steroid such as e.g. budesonide or fluticasone for delivery into the lungs via nebulization
1 ... 5527 5528 5529 5530 5531 5532 5533 5534 5535 5536 5537 5538 5539 5540 5541 5542 5543 5544 5545 5546 5547 ... 7860